Table 3.
Morphologic and functional cardiac findings.
| Parameter | Athletes (n = 47) |
|---|---|
| Cardiac magnetic resonance | |
| LV EDVi, mL/m2 | 111 ± 18 |
| LV ESVi, mL/m2 | 49 ± 10 |
| LV SVi, mL/m2 | 62 ± 10 |
| LV EF, % | 56 ± 4 |
| RV EDVi, mL/m2 | 107 ± 17 |
| RV ESVi, mL/m2 | 46 ± 10 |
| RV SVi, mL/m2 | 61 ± 10 |
| RV EF, % | 57 ± 4 |
| LAAi, cm2/m2 | 13 ± 2 |
| RAAi, cm2/m2 | 13 ± 2 |
| IVST, mm | 9 ± 1.2 |
| PWT, mm | 8 ± 1.2 |
| Pathological LGE, n (%) | 0 (0) |
| RV insertion point LGE, n (%) | 4 (8.5) |
| Pericardial effusion, n (%) | 1 (2) |
| Parametric Mapping | |
| T1 Blood, ms | 1499 ± 105 |
| T1 Myo, ms | 950 ± 36 |
| T2 Myo, ms | 50 ± 2 |
| ECV, % | 0.27 ± 0.02 |
| Positive Lake Louise Criteria, n (%) | 1 (2) |
| Echocardiography | |
| E/A | 1.7 ± 0.5 |
| E, cm/s | 77 ± 16 |
| A, cm/s | 46 ± 10 |
| e’, cm/s | 11 ± 3 |
| E/e’ | 10 ± 3 |
| TAPSE, mm | 26 ± 4 |
| sPAP, mmHg | 25 ± 3 |
ECV: extracellular volume; EDVi: end diastolic volume index; ESVi: end systolic volume index; EF: left ventricular volume index; LAAi: left atrium area index; LGE: late gadolinium enhancement; LV: left ventricle; LV mass/i: left ventricular mass index; myo: myocardium; LWT: lateral wall thickness; IVST: interventricular septum thickness; PWT: posterior wall thickness; RAAi: right atrium area index; RV: right ventricle; SVi: stroke volume index; sPAP: systolic pulmonary arterial pressure; TAPSE: tricuspid annular plane systolic excursion.